B-Lymphocyte Antigen CD20 (MS4A1) Antibody
286€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
B-Lymphocyte Antigen CD20 (MS4A1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx421507
tested applications
WB, FCM
Description
B-Lymphocyte Antigen CD20 (MS4A1) Antibody is a Mouse Monoclonal antibody for the detection of B-Lymphocyte Antigen CD20 (MS4A1) in Mouse samples.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | B-Lymphocyte Antigen CD20 (MS4A1) |
| Host | Mouse |
| Reactivity | Mouse |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Isotype | IgG2a Kappa |
| Clone ID | H389 |
| Purity | > 95% |
| Purification | Purified by Protein A/G affinity chromatography. |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | WB, FCM |
| Buffer | 0.01 M PBS, pH 7.4. |
| Availability | Shipped within 5-12 working days. |
| Storage | Store at 4 °C if the entire vial will be used within 1 week. Aliquot and store at -20 °C or -80 °C for long-term storage. Avoid repeated freeze-thaw cycles. |
| Dry Ice | No |
| UniProt ID | P19437 |
| Gene ID | 12482 |
| NCBI Accession | NP_031667.1 |
| Alias | B1,S7,Bp35,CD20,FMC7,CVID5,LEU-16,B-lymphocyte antigen CD20,B-lymphocyte surface antigen B1,Leukocyte surface antigen Leu-16,Membrane-spanning 4-domains subfamily A member 1 |
| Background | Antibody anti-MS4A1 |
| Status | RUO |
| Note | Concentration: 1.69 mg/ml - |
Descripción
Related Products
Human MS4A1 (B-lymphocyte antigen CD20) ELISA Kit
Ver Producto
MS4A1 antibody
CD20 is a 33-37 kDa transmembrane phosphoprotein. CD20 is a B-lymphocyte surface molecule that is widely expressed during B-cell ontogeny, from early pre-B-cell developmental stages until final differentiation into plasma cells. CD20 functions as calcium-permeable cation channel. It is involved in the regulation of B-cell activation and proliferation. CD20 serves as a useful target for antibody-mediated therapeutic depletion of B-cells.
Ver Producto